Description
The abstract establishes that 3dA requires RUVBL2 for circadian benefits and enhances circadian amplitude, but the molecular mechanism linking 3dA to RUVBL2-dependent transcriptional enhancement remains unexplained. Understanding this pathway is critical for developing targeted circadian therapeutics for aging.
Gap type: unexplained_observation Source paper: Restoring circadian rhythms in the hypothalamic paraventricular nucleus reverses aging biomarkers and extends lifespan in male mice. (2026, Cell, PMID:41785851)